Turner's Syndrome Clinical Trial
Official title:
Phase III Clinical Trial for Assessment of Efficacy and Safety of DA-3002 (Recombinant Human Growth Hormone) in Patients With Turner's Syndrome
A study demonstrates the non-inferiority of DA-3002 when compared with Genotropin®.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00006334 -
Turner Syndrome: Genotype and Phenotype
|
N/A | |
Not yet recruiting |
NCT02871986 -
Pubertal Induction in Individuals With Hypogonadism
|
N/A | |
Completed |
NCT01306357 -
Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device
|
||
Completed |
NCT00001221 -
Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome
|
Phase 2 | |
Completed |
NCT00250250 -
An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG
|
Phase 3 | |
Completed |
NCT00004275 -
Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome
|
Phase 2 | |
Completed |
NCT00001253 -
The Effects of Estrogen on Cognition in Girls With Turner Syndrome
|
Phase 2 | |
Completed |
NCT00013546 -
Hormone Replacement Therapy to Treat Turner Syndrome
|
Phase 2 | |
Terminated |
NCT02018172 -
Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device
|
N/A | |
Completed |
NCT01066052 -
Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
|
Phase 4 | |
Completed |
NCT00004274 -
Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome
|
N/A | |
Completed |
NCT00001343 -
The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome
|
Phase 2 | |
Terminated |
NCT00870220 -
Initiating Transdermal Estradiol Therapy in Turner's Syndrome
|
Phase 1 |